Phase Genomics Appoints David Shoultz As Chief Business Officer

Oct 09, 2024•10 months ago

Position

Chief Business Officer

Company

Phase Genomics

David Shoultz

SeattleScience And EngineeringData And Analytics

Description

Phase Genomics, Inc. has announced the appointment of David Shoultz, PhD, MBA as the company’s first Chief Business Officer. Shoultz will drive growth as Phase Genomics accelerates market awareness and its work to amplify the impact of technological innovation at the frontiers of human health.

Company Information

Company

Phase Genomics

Location

4000 MASON ROAD

Seattle, Washington, United States

About

Phase Genomics applies proprietary ultra-long-range genome sequencing technology to enable genome assembly, microbiome discovery, as well as analysis of genomic integrity and chromosomal aberrations. In addition to a comprehensive portfolio of laboratory and computational services and products, including reagent kits and genomic services, they also offer an industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months